CURRICULUM VITAE
Charlotte DeCroes Jacobs, M.D.
Drs. Ben and A. Jess Shenson Professor of Medicine (Emerita)
Department of Medicine, Division of Oncology
Stanford University School of Medicine
Personal History:
Place of Birth: Oakridge, Tennessee
Date of Birth: January 27, 1946
Education:
1968 BA Magna Cum Laude, University of Rochester, Rochester NY
1972 MD Washington University School of Medicine, St. Louis MO
Postgraduate Training:
1972-74 Intern, Junior Resident, Department of Medicine
Washington University School of Medicine, St. Louis MO
1974-75 Senior Resident, Department of Medicine,
University of California, San Francisco CA
1975-77 Postdoctoral Fellow, Division of Oncology
Stanford University School of Medicine, Stanford CA
Academic Appointments:
2009- Professor of Medicine (Emerita) Stanford University
1996-2009 Professor of Medicine, Division of Oncology, Stanford University
1992-96 Associate Professor of Medicine, Division of Oncology
1986-92 Associate Professor of Medicine (Clinical), Division of Oncology
1980-86 Assistant Professor of Medicine, Division of Oncology
1977-80 Acting Assistant Professor of Medicine, Division of Oncology
Administrative Appointments:
2010- Staff physician, VA Palo Alto Health Care System
1997-01 Director, Clinical Cancer Center at Stanford
1998-99 Director, Clinical Cancer Program, UCSF Stanford Health Care
1990-97 Senior Associate Dean for Education and Student Affairs, School of Medicine
1988-90 Co-director, Fellowship Training Program, Division of Oncology
1977-90 Director, Oncology Day Care Center, Stanford University Medical Center
Honors:
Undergraduate:
1968 Phi Beta Kappa
1968 Janet Park Howell Award in Science
Medical School:
1971 Alpha Omega Alpha
1972 Missouri State Medical Association Award
1972 Janet Glasgow Scholastic Citation Award
1971 Medical Alumni Scholarship Award
1969-70 Lange Medical Book Award
Faculty:
1981 American Cancer Society, Junior Faculty Scholarship
1987-89 University Fellow
1983-87 Kaiser Foundation Award for Clinical Teaching
1986 Kaiser Foundation Award for Innovative and Outstanding Contribution
to Medical Education
1985 Kaiser Foundation Award for Preclinical Teaching
1990 Presidential Citation from American Society for Head and Neck Surgery
1990 Arthur L. Bloomfield Award for Excellence in Teaching Clinical Medicine
1990 Alwin C. Rambar Award for Excellence in Patient Care
1991 Kaiser Foundation Award for Excellence in Clinical Teaching
1993 Kaiser Foundation Award for Innovative and Outstanding
Contribution to Medical Education
1993 Aphrodite Hofsommer Award for outstanding academic accomplishments,Washington University
1995 Laura Hadad Visiting Professorship, Georgetown University
1997 Patricia R. Woodard Memorial Lecture, St. Francis Memorial Hospital,
San Francisco, CA
1997 Edwin C.Yoder Honor Lecture, St. Joseph Medical Center, Tacoma, WA
1999 Drs. Ben and A. Jess Shenson Professorship in the School of Medicine
2002 Alumni Achievement Award, Washington University School of Medicine,
St. Louis
2007 Distinguished Alumni Award, Washington University in St. Louis
2007 American Society of Clinical Oncology Statesman Award
Professional Memberships:
Alpha Omega Alpha
American Society of Clinical Oncology
Amnesty International
National Committees and Administrative Activities:
2005 -10 National Comprehensive Cancer Network (NCCN) Soft Tissue Sarcoma
Guidelines Committee
2000 Editorial Board, Current Treatment Options in Oncology
1999 -10 National Comprehensive Cancer Network (NCCN) Unknown Primary
Guidelines Committee
1998-02 Cancer Research Council, Department of Health Services, State of California
Vice Chairman, 1999-02
1996-98 American College of Physicians, Writing Committee for
Medical Knowledge Self Assessment Program (MKSAP) XI
1994-01 National Comprehensive Cancer Network (NCCN) Board of Directors
American Society of Clinical Oncology
1992-95 Board of Directors
1995 Strategic Planning Group
1994 Oncology Manpower Committee
1994-95 Conflict of Interest Subcommittee
1993-95 Health Services Committee
1989 Nominations Committee
1986 Education Planning Committee
1990 Third International Conference on Head and Neck Cancer Program Committee
1989-90 American Society for Head and Neck Surgery Scientific Program Committee
1987 American College of Physicians, Writing Committee for MKSAP VIII
1985-88 PDQ Extramural Board Reviewer
1985-87 American Federation of Clinical Research, Stanford Representative
1984-86 Head and Neck Intergroup, Founder and first Chairman
1982-86 National Head and Neck Contracts Group
Executive Committee, Writing Committee
1982-86 FDA Oncologic Drug Advisory Board
1991-92 Editorial Board, Current Opinion in Oncology
1987-93 Editorial Board, Head and Neck Surgery
1987 Editorial Board, American Journal of Clinical Oncology
University Committees and Administrative Activities:
2008-10 Committee on Trusteeship, Board of Trustees, Stanford University
2008-09 Search Committee, Thoracic Oncology (Chair)
2008-09 Medical Oncology Task Force
2008 Search Committee, Orthopedic Oncology
2007 Scientific Review Committee, Cancer Center
2007-09 Disease Leadership Group, Sarcoma
2006-09 Search Committee, Director Breast Cancer Program
2005 -06 Search Committee, Head & Neck Oncology (Chair)
2005 -06 Executive Advisory Committee of the Office of Diversity and Leadership
2005 -06 Disease Management Group, Stanford Cancer Center
2005 LCME Subcommittee on Educational Objectives and Structure
2004 -08 Search Committee, Ophthalmology
2004 -05 Search Committee, GI Oncology
2004 -05 Search Committee, Head & Neck Surgery
2004-06 Stanford University Faculty Senate
University Senate Steering Committee, 2005-2006
2003 Center for Cancer Treatment and Prevention Business Planning Executive Group
2003 Oncology Informatics Steering Committee
2002-03 Search Committee, Otolaryngology/Head and Neck Surgery
2001 -02 Search Committee, Neuro-Oncology
2001 Medical Education Strategic Planning Committee
2000-01 Medical Center Strategic Planning Group
2000-01 Medical Center Internal Governing Council
2000 Dean’s Search Committee, School of Medicine
1999 -2009 Executive Committee, Northern California Tumor Board at Silverado
University Committees and Administrative Activities (Continued):
1998-99 Strategic Alliance Group, UCSF Stanford Health Care
1998-99 International Advisory Committee, UCSF Stanford Health Care
1998-99 Cancer Leadership Group, UCSF Stanford Health Care
1998-99 Cancer Center Steering Committee, UCSF Cancer Center
1997-99,99-01 Stanford University Faculty Senate
University Senate Steering Committee, 2000-01
1994 - Clinical Cancer Center Steering Committee
1993-94 Commission on Undergraduate Education
1993-94 President's Medical Center Task Force – External Affiliations Working Group
1993 Provost’s Committee on Postdoctoral Scholars, Chair
1992-93 Provost’s Committee on Budget Implementation
1992-93, 94-96 Council on Diversity, School of Medicine
1992 University Commencement Committee
1988-92,94-96 Stanford University Faculty Senate
Committee on Committees, 1989-90, 95-96
1983-89 Medical School Faculty Senate
Chairman, 1988-89
Committee of Five, 1983-84, 87-89
1988-89 Affirmative Action Committee, School of Medicine
1988-89 Committee on Student Awards, Chairman
1988-89 Management Group to the Chairman, Department of Medicine
1988-89 Committee on Faculty Practice Program Organization and Financial Relationships
1988-89 Search Committee, Gynecology and Obstetrics Chair
1988-90 Planning Group for Cancer Treatment Center
1986-88 Faculty Practice Program Strategic Planning Committee
1986-90 File Reviewer for Admissions Committee, School of Medicine
1985-87 Faculty Practice Budget Committee, Department of Medicine
1985-87 Principal Investigator at Stanford, Northern California Oncology Group (NCOG)
Chairman, Head and Neck Committee
Member, Pharmacology and Lymphoma Committees
1982-87 Committee on Well-Being of Medical Students
Chairman, 1982-84
1981-89 Professional Practice Committee
1981-85 Internship Selection Committee, Department of Medicine
Certification:
1972 National Board of Medical Examiners
1975 American Board of Internal Medicine
1977 American Board of Internal Medicine (Medical Oncology)
License:
1974 California
PUBLISHED ARTICLES
1. DeCroes C*, Abood LG. Histology of a uniquely organized nervous system in the salamander neural tissue-limb implant. Int J Neurosci 1972;3:237-50.
2. Jacobs C, Portlock CS, Rosenberg SA. Prednisone in MOPP chemotherapy for Hodgkin's disease. Br Med J 1976;2:1469-71.
3. Kim H, Jacobs C, Warnke RA, Dorfman RF. Malignant lymphoma with high content of epitheloid histiocytes. Cancer 1978;41:620-35.
4. Jacobs C, Bertino JR, Goffinet DR, Fee WE, Goode RL. Cis-platinum chemotherapy in head and neck cancers. Otolaryngol Head Neck Surg 1978;86:780-3.
5. Jacobs C, Bertino JR, Goffinet DR, Fee WE, Goode RL. 24-hour infusion of cis-platinum in head and neck cancers. Cancer 1978;42:2135-40.
6. Jacobs C. A patient teaching tool - Hodgkin's disease. Cancer Nursing 1979;2:153-66.
7. Levi J, Jacobs C, Kalman SM, McTigue M, Weiner MW. Mechanism of cis-platinum nephrotoxicity: I. Effects on sulfhydryl groups in rat kidneys. J Pharmacol Exp Ther 1980;213:545-50.
8. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 1980;213:551-6.
9. Jacobs C, Kalman SM, Tretton M, Weiner MW. Renal handling of cis-diamminedichloroplatinum (II). Cancer Treat Rep 1980;64:1223-6.
10. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med 1981;95:669-75.
11. Mead GM, Jacobs C. Changing role of chemotherapy in the treatment of head and neck cancer. Am J Med 1982;73:582-95.
12. Jacobs C. Chemotherapy and combined modality treatment of head and neck cancer. Current Concepts in Oncology, 1982:4:17-21.
13. Jacobs C. Use of methotrexate and 5-FU for recurrent head and neck cancer. Cancer Treat Rep 1982;66:1925-8.
14. Jacobs C, Ross RD, Walker IM, Stockdale FE. Behavior of cancer patients: A randomized study of the effects of education and peer support groups. Am J Clin Oncol 1983;6:347-50.
15. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S. A randomized phase III study of
cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and
neck. Cancer 1983;52:1563-9.
*Maiden Name
16. Campbell AB, Kalman SM, Jacobs C. Plasma platinum levels: Relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep 1983;67:169-72.
17. Coleman CN, Friedman MK, Jacobs C, Halsey J, Ignoffo R, Leibel S, Hirst VK, Gribble M, Carter SK, Phillips TL. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer Misonidazole. Cancer Res 1983;43:5022-5.
18. Jacobs C, Coleman CN, Rich L, Hirst K. Weiner MW. Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid. Cancer Res 1984;44:3632-5.
19. Schreiber DP, Jacobs C, Rosenberg SA, Cox RS, Hoppe RT. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys 1985;11:31-6.
20. Jacobs C, Hoppe RT. Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985;11:357-64.
21. Connors JM, Andiman WA, Howarth CB, Liu E, Merigan TC, Savage ME, Jacobs C. Treatment of nasopharyngeal carcinoma with human leukocyte interferon. J Clin Oncol 1985;3:813-7.
22. Kent DL, Shortliffe EH, Carlson RW, Bischoff MB, Jacobs CD. Improvements in data collection through physician use of a computer-based chemotherapy treatment consultant. J Clin Oncol 1985;3:1409-17.
23. Hickam DH, Shortliffe EH, Bischoff MB, Scott AC, Jacobs CD. The treatment advice of a computer-based cancer chemotherapy protocol advisor. Ann Intern Med 1985;103:928-36.
24. Jacobs C, Weiss L, Hoppe RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg 1986;112:654-8.
25. Bernstein JI, Jacobs C, Meyers F, Rich-Goffinet L, Tanaka L. A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol 1986;9:58-60.
26. Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987;5:1410-8.
27. Tseng A Jr., Jacobs C, Coleman CN, Horning SJ, Lewis BJ, Rosenberg SA. Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate. Cancer Treat Rep 1987;71:475-8.
28. Venook AP, Tseng A Jr., Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: A pilot study of the Northern California Oncology Group. J Clin Oncol 1987;5:951-5.
29. Jacobs C. Treatment of recurrent squamous cell head and neck cancer. Advances in Oncology 1987;3:16-22.
30. Jacobs C.* Adjuvant chemotherapy for advanced head and neck squamous carcinoma. A Final Report of the Head and Neck Contracts Program. Cancer 1987;60:301-11.
31. Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee W. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 1987;60:1178-83.
32. Tseng A Jr., Jacobs C, Coleman CN, Horning SJ, Lewis BJ, Rosenberg SA. Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin. Cancer Treat Rep 1987;71:659-60.
33. Coleman CN, Carlson RW, Halsey J, Kohler M, Gribble M, Sikic BI, Jacobs C. Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole. Cancer Res 1988;48:3528-32.
34. Levick S, Jacobs C, Loukas DF, Gordon DH, Meyskens FL, Uhm K. Naproxen sodium in treatment of bone pain due to metastatic cancer. Pain 1988;35:253-8.
35. Dimery IW, Jacobs C, Tseng A, Saks S, Pearson G, Hong WK, Gutterman JU. Recombinant5interferon-gammain the treatment of recurrent nasopharyngeal carcinoma. J Biol Resp Mod 1989;8:221-6.
36. Audeh MW, Jacobs CD, Davis TE, Carlson RW. A phase II trial of carbetimer for the treatment of colorectal cancer: a trial of the Northern California Oncology Group. Am J Cln Oncol. 1990;13(4): 324-6.
37. Jacobs C, Makuch R.. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer - a subset analysis of the head and neck contracts program. J Clin Oncol 1990;8:838-47.
38. Berry JM, Jacobs C, Sikic BI,Halsey J, Borch R. Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol 1990;8:1585-90 .
39. Jacobs C. The internist in the management of head and neck cancer. Ann Intern Med 1990;113(10):771-8.
40. Jacobs C, Kaubisch S, Halsey J, Lum B, Gosland M, Coleman CN, Sikic B. Use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 1991;67(6):1518-24.
41. Vokes EE, Dimery I, Jacobs CD, et al. A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer. Cancer 1991 67(9):2253-57.
42. Jacobs C. Neoadjuvant and adjuvant treatment of head and neck cancer. Seminars in Oncology 1991;18:504-14.
* Writing Committee
43. Jacobs C, Lyman G, Velez-Garcia, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992;10:257-63.
44. Nelson M, Jacobs C, Cuban L. Concepts of Curriculum. Teaching and Learning in Medicine 1992;4:202-5
45. Jacobs C, Moreno B, Blaschke T. In Progress: A multimodality approach to preparation for clinical medicine. Acad Med 1995;70(5):441-2.
46. Jacobs C, Bergen M. In Progress: A sexual harassment workshop for medical students. Acad Med 1995;70(5):434-5.
47. Jacobs C, Pinto H. Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Seminars in Oncology 1995;22(6):540-52.
48. Jacobs CD, Cross PC. The value of medical student research — the experience at Stanford University School of Medicine. Medical Education 1995;29:342-6.
49. Bergen MR, Guarino CM, Jacobs CJ. A climate survey for medical students: a means to assess change. Evaluation and the Health Professions 1996;19(1):30-47.
50. Smith K, Moreno E, Jacobs C. The curriculum indexing database for Stanford University School of Medicine. Teaching and Learning in Med 1996; 8(1): 48-52.
51. Jacobs CJ, Van der Pas M. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Oncol 1996; 10:16-20.
52. Amer Soc Clin Oncol (Mayer RJ, Antman KH, Bailes JS, Bloomfield CD, Canellos GP, Glick JG, Jacobs CD). Status of the Medical Oncology Workforce. J Clin Onc 1996;14(9):2612-21.
53. Vosti KL, Bloch DA, Jacobs CD. The relationship of clinical knowledge to months of clinical training among medical students. Acad Med 1997;72(4):305-7.
54. Ciesielski-Carlucci C, Leong P, Jacobs C. A case report of anaphylaxis from cisplatin/taxol and a review of their hypersensitivity reaction profiles. Am J Clin Onc 1997;20(4):373-5.
55. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Non-Hodgkin’s lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am 1997;3(5):303-11.
56. Vosti KL, Jacobs CD. Outcome measurements in postgraduate year one of graduates from a medical school with a pass/fail grading system. Acad Med 1999;74(5):547-9.
57. Yuen A, Jacobs C. Lymphomas of the Head and Neck. Sem in Oncol 1999;26(3): 338-45.
58. Jacobs CD, Bergen MR, Korn D. Impact of a program to diminish gender insensitivity and sexual harassment at a medical school. Acad Med 2000;75:464-9.
59. Nguyen DD, Loo BW Jr, Tillman G, Natkunam Y, Cao TM, Vaughan W, Dorfman RF, Goffinet DR, Jacobs CD, Advani RH. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003 Aug;82(8):521-5. Epub 2003 May 29.
60. Advani R, Lum BL, Fisher GA, Halsey J, Chin DL, Jacobs CD, Sikic BI. A phase I trial of liposomal doxorubicin, paclitaxel, and valspodar (PSC-833), an inhibitor of multidrug resistance. Ann Oncol. 2005 Aug;16:1968-1973
61. Demetri GD, Baker LH, Benjamin RS, Casper ES, Conrad EU 3rd, D’Amato GZ, DeLaney TF, Ettinger DS, Heck R Jr., Heslin MJ, Hutchison RJ, Jacobs CD, et al. Soft tissue sarcoma. J Natl Compr Canc Netw. 2007 Apr;5(4):364-99.
62. Lehman NL, Jacobs CD, Holsten PA, et al. Primary paraspinal leiomyosarcoma invading the cervical spinal canal successfully treated with surgery, radiotherapy, and chemotherapy. Case report. J Neurosurg Spine. 2007 May;6(5):441-6.
63. Elkin A, Jacobs C. Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases. J Cancer Res Clin Oncol (2008) 134:1151-1153
64. Ettinger DS, Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handord C, Harris El, Jacbos CD, et al. Occult Primary. J Natl Compr Canc Netw. 2008 Nov;6(10):1026-60
65. Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. The value of surgery for retroperitoneal sarcoma. Sarcoma. 2009, Epub 2009 Oct. 8
66. Chandran S, Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA. Imatinib in the treatment of nephrogenic systemic fibrosis. Am J Kidney Dis. 2009 Jan;53(1):129-32.
67. Brar R, West R, Witten D, Raman B, Jacobs C, Ganjoo K. Breast angiosarcoma: Case series and expression of vascular endothelial growth factor. Case Rep Oncol 2009; 2:242-50
68. Ganjoo K, Jacobs C. Antiangiogenesis agents in the treatment of soft tissue sarcomas. Cancer. 2010 Mar 1;116(5):1177-83.
69. Ganjoo K, Witten D, Patel M, Espinosa I, La T, Tibshirani, van de Rijn M, Jacobs C, West RB. The prognostic value of tumor associated macrophages in leiomyosarcoma: a single institution study. Amer J Clin Oncol (in press).
70. Ganjoo KN, Demetri GD, Jacobs C, Patel S. Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevac. Leuk Lymphoma. 2009; 50 (11): 1882-4.
71. Wakelee HA, Takimoto CH, Lopez-Anaya A, Chu Q, Middleton G, Dunlop D, Ramlau R, Leighl N, Rowinsky EK, Hao D, Zatloukal P, Jacobs CD, Rodon J. The effect of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2011.
72. Wakelee HA, Middleton G, Dunlop D, Ramlau R, Leighl N, Hao D, Lopez-Anaya A, Zatloukal P, Jacobs CD. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small cell lung cancer (NSCLC). Chemother Pharmacol. 2011.
PUBLISHED CONFERENCE PROCEEDINGS
1. Weiner MW, Jacobs C. Mechanism of cisplatin nephrotoxicity. Fed Proc Symposium on Metal Toxicity 1983;42:2974-8.
2. Jacobs C. Probenecid and diethyldithiocarbamate as modifiers of cisplatin toxicity. In: Howell SB (ed) Proceedings of the Sixth International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. New York: Plenum Publishing Corp 1991;493-500.
PUBLISHED BOOKS/SYMPOSIA
1. Jacobs C (ed). Cancers of the Head and Neck. MA: Martinus Nijhoff Publishers, 1987.
2. Medical Knowledge Self-Assessment Program VIII. American College of Physicians, 1988.
3. Jacobs C, Goffinet DR, Fee WE. Head and Neck Squamous Cancers. Year Book Medical Publishers, Chicago, Jan/Feb 1990.
4. Jacobs C, (ed). Carcinomas of the Head and Neck. Boston: Kluwer Academic Publishers, 1990.
5. Medical Knowledge Self-Assessment Program VIII. American College of Physicians, 1998.
6. Jacobs CD. Henry Kaplan and the Story of Hodgkin’s Disease.
Stanford: Stanford Press, 2010.
PUBLISHED BOOK CHAPTERS
1. Jacobs C. The role of cisplatin in the treatment of recurrent head and neck cancer. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin Current Status and New Developments. New York: Academic Press, 1980;423-30.
2. Jacobs C. High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer. In: Carter SK, Sakurai Y, Umezawa H (eds) Recent Results in Cancer Research. Berlin: Springer-Verlag, 1981;290-5.
3. Jacobs C, Ross R. Psychological assessment of cancer patients. In: Williams CJ, Whitehouse JMA (eds) Recent Advances in Clinical Oncology. London: Churchill Livingstone, 1982;365-74.
4. Jacobs C. The use of chemotherapy in combination with radiotherapy in the treatment of head and neck squamous cancers. In: Wolf GT (ed) Head and Neck Oncology. Boston: Martinus Nijhoff Publishers, 1984;265-86.
5. Shortliffe EH, Scott AC, Bischoff MB, Campbell AB, van Melle W, Jacobs CD. An expert system for oncology protocol management. Rule-based expert systems. In: Buchanan BG, Shortliffe EH (eds) The Mycin Experiments of the Stanford Heuristic Programming Project. CA: Addison-Wesley Company, 1984;653-65.
6. Jacobs CD. The role of chemotherapy in the treatment of head and neck cancer. In: Sikic BI, Rozencweig M, Carter SK (eds) Bleomycin Chemotherapy. New York: Academic Press, 1985;79-93.
7. Jacobs C. The handling of platinum by the human kidney. In: McBrien DCH, Slater TF (eds) Biochemical Mechanisms of Platinum Antitumor Drugs. Oxford: IRL Press Limited, 1986;147-70.
8. Jacobs CD. Biophysiology of antineoplastic chemotherapy for head and neck cancer. In: Cummings CW, Fredrickson, Harker LE, Krause CJ, Schuller DE (eds) Otolaryngology-Head and Neck Surgery. St. Louis: C.V. Mosby Co, 1986;51-72.
9. Connors JM, Jacobs C. Nasopharyngeal carcinoma: Relationship to Epstein-Barr virus and treatment with Interferon. In: Jacobs C (ed) Cancers of the Head and Neck. MA: Martinus Nijhoff Publishers, 1987;167-75.
10. Jacobs C. Lymphomas of extranodal head and neck sites. In: Jacobs C (ed) Cancers of the Head and Neck. MA: Martinus Nijhoff Publishers, 1987;269-84.
11. Jacobs CD. Head and neck cancers. In: Wittes R (ed) Manual of Oncologic Therapeutics. Philadelphia: J.B. Lippincott Co, 1989;212-22.
12. Jacobs C. Head and Neck Cancer. In: Magrath I (ed) New Directions in Cancer Treatment. Berlin: Springer-Verlag, 1989;455-58.
13. Audeh MW, Jacobs C, Rice D. Anaplastic carcinoma, lymphoma, and unusual Malignancies, and chemotherapy for thyroid cancer. In: Falk SA (ed) Thyroid Disease. New York: Raven Press, 1990;527-535.
14. Jacobs CD. Prevention and management of regional and distant metastasis: Introduction. In: Fee WE, Goepfert H, Johns MA, Strong EW, Ward PH (eds) Head and Neck Cancer vol 2. Philadelphia: BC Decker Inc 1990; 239.
15. Haselow RE, Warshaw MG, Oken MM, Adams GL, Aughey JL, Cooper JS, Schuller DE, Jacobs CD. Radiation alone versus radiation with weekly low dose cis-platinum in unresectable cancer of the head and neck. In: Fee WE, Goepfert H, Johns MZ, Strong EW, Ward PH (eds) Head and Neck Cancer vol 2. Philadelphia: BC Decker Inc 1990;279-281.
16. Jacobs CD, Goffinet DR, Fee WE Jr. The use of chemotherapy for organ preservation in the treatment of advanced resectable head and neck cancer. In: Fee WE, Goepfert H, Johns MA, Strong EW, Ward PH (eds) Head and Neck Cancer vol 2. Philadelphia: BC Decker Inc 1990;295-297.
17. Jacobs C. Etiologic considerations for head and neck squamous cancers. In: Jacobs C (ed) Carcinomas of the Head and Neck. Boston: Kluwer Academic Publishers 1990;265-282.
18. Pinto H, Jacobs CD. Chemotherapy for recurrent and metastatic head and neck cancer. In: Hematology/Oncology Clinics of North America. Philadelphia: WB Saunders Co 1991;667-686.
19. Jacobs CD. Head and neck cancers. In: Manual of Oncologic Therapeutics. Philadelphia: JB Lippincott 1991;154-160.
20. Forastiere AA, Jacobs CD. Biophysiology of antineoplastic chemotherapy for head and neck cancer. In: Cummings CW (eds) Otolaryngology-Head and Neck Surgery. St. Louis:Mosby Year Book 1993;116-142.
21. Jacobs C. Lymphoma of the head and neck. In: Bailey BB (ed) Head and Neck Surgery - Otolaryngology. Philadelphia: J. B. Lippincott Co. 1993;1221-1228.
22. Pinto HA, Jacobs C. Combined modality treatment of head and neck squamous cancers. In: Niederhuber JE (ed) Current Therapy in Oncology. Philadelphia: BC Decker 1993;157-161.
23. Pinto HA, Jacobs C. Distant metastases from head and neck squamous cancers: The role of adjuvant chemotherapy. In: Hong WK and Weber RS (eds) Head and Neck Cancer. Boston: Kluwer Academic Publishers 1995;243-262.
24. Pinto HA, Jacobs C. Head and neck cancer –– combined modality therapy and chemotherapy. In: Brian MC and Carbone PP (eds) Current Therapy in Hematology-Oncology. St. Louis: Mosby 1995;352-358.
25. Jacobs C, Pinto HA. Head and neck cancers. In: Macdonald JS, Haller DG and Mayer RJ (eds) Manual of Oncologic Therapeutics, 3rd edition. Philadelphia: J.B. Lippincott 1995; 162-169.
26. Jacobs C, Yuen A. Lymphomas of the Head and Neck. In: Bailey BJ (ed) Head and Neck Surgery -- Otolaryngology. Philadelphia: Lippincott-Raven 1998; 1595-1603.
27. Yuen A, Jacobs C. Lymphomas of the Head and Neck. In: Bailey BJ (ed) Head and Neck Surgery – Otolaryngology, Third Edition. Philadelphia: Lippincott Williams & Wilkins, 2001, 1379-1384.
28. Advani R, Jacobs C. Lymphomas of the Head and Neck. In Bailey BJ (ed) Head and Neck Surgery – Otolaryngology, Fourth Edition. (In press)
PUBLISHED LETTERS & EDITORIALS
1. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Pregnancy and Hodgkin's disease (Letter). Ann Intern Med 1982;96:532.
2. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Hodgkin's disease and the pregnant patient (Letter). Ann Intern Med 1982;96:682.
3. Jacobs C. Systemic therapy of head and neck cancer. A commentary. Oncology 1989;88-97.
4. Jacobs C. Adjuvant chemotherapy for head and neck cancer. Editorial. J Clin Oncol 1989;7:823-826.
5. Jacobs C, Sikic B. Re: Modification of cisplatin toxicity with diethyldithiocarbamate (Letter).
J Clin Oncol 1991;9(4):706.
6. Jacobs C, Pinto HA. Head and neck cancer with an occult primary tumor. N Eng J Med 1992;326:58-59.
7. Jacobs C. Head and neck cancer in 1994: A change in the standard of care. J Natl Cancer Inst 1994;86: 250-2.
8. Moreno E, Jacobs C, Nelson M. Medical education journal club (Letter). Acad Med 1995;70(7):562.
9. Ganjoo KN, Demetri GD, Jacobs C, Patel S. Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec. Leuk Lymphoma. 2009 Nov;50(11):1882-4